Pesquisa sobre:
CERTOLIZUMAB PEGOL
Descritores Encontrados:
1
Mostrando:
1 .. 1
1 / 1
DeCS
Descritor
Inglês
:
Certolizumab Pegol
Descritor
Espanhol
:
Certolizumab Pegol
Descritor
Português
:
Certolizumab Pegol
Categoria:
D05.750.741.125
D12.644.541.500.650.250
D12.776.124.486.485.114.224.060.500
D12.776.124.486.485.680.650.250
D12.776.124.790.651.114.224.060.500
D12.776.124.790.651.680.650.250
D12.776.377.715.548.114.224.200.500
D12.776.377.715.548.680.650.250
D25.720.741.125
J01.637.051.720.741.125
Definição
Inglês
:
A polyethylene-glycolated Fab' fragment of TUMOR
NECROSIS
FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and
IL-1 BETA
and is used to treat
RHEUMATOID ARTHRITIS
and PSORIATIC
ARTHRITIS.
Nota Histórica
Inglês
:
2016 (2003)
Qualificadores Permitidos
Inglês
:
AD
administration & dosage
AE
adverse effects
AG
agonists
AA
analogs & derivatives
AN
analysis
AI
antagonists & inhibitors
BL
blood
CF
cerebrospinal fluid
CS
chemical synthesis
CH
chemistry
CL
classification
CT
contraindications
EC
economics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism
PK
pharmacokinetics
PD
pharmacology
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use
TO
toxicity
UR
urine
Número do Registro:
55953
Identificador Único:
D000068582
Ocorrência na BVS
:
Similar:
DeCS
CID-10
SciELO
LILACS
LIS